Clinical Trial

Safety and Economics of Parenchymal Transection in Minimally Invasive Liver Surgery

Study acronym: LIVER-MIND 2
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
LIVER-MIND 2 is a multicentre, observational, retrospective registry coordinated by the SICE HPB and Minimally Invasive Surgery Working Group, enrolling consecutive adults undergoing elective minimally invasive (laparoscopic, robotic or hybrid) liver resection between January 2021 and December 2025 across ≥15 high-volume or dedicated centres (target \>30 centres).
Trial Details
NCT Number NCT07750275
Lead Sponsor University of Molise
Conditions Liver Surgery, MINIMALLY INVASIVE LIVER SURGERY, Liver Neoplasm
Enrollment 800 participants
Start Date 2021-01-01
Primary Completion 2026-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-06